hsa-miR-3166 antagomir
Product Specifications
UNSPSC Description
hsa-miR-3166 antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
Target Antigen
MicroRNA
Type
Oligonucleotides
Related Pathways
Epigenetics
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hsa-mir-3166-antagomir.html
Solubility
10 mM in H2O
Molecular Weight
7742.993
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-RI00622A/hsa-miR-3166-antagomir-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-RI00622A/
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6357892-01 0.2 mL
TRAF4, CT (TRAF4, CART1, MLN62, RNF83, TNF receptor-associated factor 4, Cysteine-rich domain associated with RING and Traf domains protein 1, Metastatic lymph node gene 62 protein, RING finger protein 83) (Biotin)
Ask
View Details 
MBS6357892-02 5x 0.2 mL
TRAF4, CT (TRAF4, CART1, MLN62, RNF83, TNF receptor-associated factor 4, Cysteine-rich domain associated with RING and Traf domains protein 1, Metastatic lymph node gene 62 protein, RING finger protein 83) (Biotin)
Ask
View Details 
